Metabolomics for Pharmaceutical Applications Volume 2
Clinical trials require significant financial investment and time commitment. Although they are necessary for drugs to reach patients, a large proportion of clinical trials fail. These failures raise the overall cost of executing clinical trials and delay the arrival of drugs to the market, which means patients must wait longer for the drugs they need and pay more for them when they can finally get them. Better insights mean fewer failures. With Metabolon’s targeted and global metabolomics panels, you gain unprecedented insights into the impact and mechanism of action of your drug. These insights can be used to develop a clinical trial protocol designed to maximize the chances of success. This book highlights some of these successes.